Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity
Authors
Keywords
-
Journal
Pharmaceutics
Volume 7, Issue 3, Pages 137-151
Publisher
MDPI AG
Online
2015-07-23
DOI
10.3390/pharmaceutics7030137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of neurological disorders by introducing mRNA in vivo using polyplex nanomicelles
- (2015) Miyuki Baba et al. JOURNAL OF CONTROLLED RELEASE
- Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
- (2014) Raquel P Deering et al. Expert Opinion on Drug Delivery
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Modified Foxp3 mRNA protects against asthma through an IL-10–dependent mechanism
- (2013) Lauren E. Mays et al. JOURNAL OF CLINICAL INVESTIGATION
- Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells
- (2013) Oliwia Andries et al. JOURNAL OF CONTROLLED RELEASE
- Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
- (2013) Lior Zangi et al. NATURE BIOTECHNOLOGY
- Efficient genome editing in zebrafish using a CRISPR-Cas system
- (2013) Woong Y Hwang et al. NATURE BIOTECHNOLOGY
- Reprogramming human fibroblasts to pluripotency using modified mRNA
- (2013) Pankaj K Mandal et al. Nature Protocols
- In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle
- (2013) Satoshi Uchida et al. PLoS One
- Systemic Delivery of Modified mRNA Encoding Herpes Simplex Virus 1 Thymidine Kinase for Targeted Cancer Gene Therapy
- (2012) Yuhua Wang et al. MOLECULAR THERAPY
- Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
- (2012) Charlotte Pollard et al. MOLECULAR THERAPY
- Cell uptake survey of pegylated nanographene oxide
- (2012) M Vila et al. NANOTECHNOLOGY
- Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
- (2011) Michael S D Kormann et al. NATURE BIOTECHNOLOGY
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Targeted Genome Editing Across Species Using ZFNs and TALENs
- (2011) Andrew J. Wood et al. SCIENCE
- Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA
- (2010) Luigi Warren et al. Cell Stem Cell
- mRNA as gene therapeutic: How to control protein expression
- (2010) Geertrui Tavernier et al. JOURNAL OF CONTROLLED RELEASE
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
- (2008) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases
- (2008) Yannick Doyon et al. NATURE BIOTECHNOLOGY
- A secreted luciferase for ex vivo monitoring of in vivo processes
- (2008) Thomas Wurdinger et al. NATURE METHODS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now